Gen Ilac
Mustafa Kemal Mahallesi 2119. Cad. No:3, Çankaya, Ankara, 06520, Turkey
Overview
Gen Ilac is a pharmaceutical company that supplies products used in the treatment of rare diseases and disorders in Neurology, Endocrinology, Nephrology, Oncology, Hematology, and Pediatric branches.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Medical
- Pharmaceutical
Investment portfolio
- Galventa
Led · Seed · Oct 2021
Galventa, founded in 2018 and based in St. Gallen, develops nutraceuticals using clinically tested galenic platform technologies aimed at synchronising circadian rhythms. Its lead product, B・SYNC ON, is described as a world-first delayed-release wake-up supplement containing caffeine, vitamin B5 and B12, and zinc B to reduce tiredness and boost mental performance. The formulation is intended to help people wake up naturally after a full night’s sleep with sharper focus and a more positive mood. Galventa is part of the Founders Factory accelerator program and has conducted initial market tests ahead of a wider commercial launch. The company will use the €696K seed funding to expand its team, broaden its product portfolio, and scale up production. It plans to launch B・SYNC ON into European markets including Switzerland, Germany and the UK.
Team
No current team members are available.